These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


166 related items for PubMed ID: 15330229

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics.
    Miller CH, Mohr F, Umbricht D, Woerner M, Fleischhacker WW, Lieberman JA.
    J Clin Psychiatry; 1998 Feb; 59(2):69-75. PubMed ID: 9501888
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of antiparkinson agents in preventing antipsychotic-induced extrapyramidal symptoms.
    Murphy JE, Stewart RB.
    Am J Hosp Pharm; 1979 May; 36(5):641-4. PubMed ID: 36755
    [Abstract] [Full Text] [Related]

  • 4. Comparison of treatment-emergent extrapyramidal symptoms in patients with bipolar mania or schizophrenia during olanzapine clinical trials.
    Cavazzoni PA, Berg PH, Kryzhanovskaya LA, Briggs SD, Roddy TE, Tohen M, Kane JM.
    J Clin Psychiatry; 2006 Jan; 67(1):107-13. PubMed ID: 16426096
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study.
    Sramek JJ, Simpson GM, Morrison RL, Heiser JF.
    J Clin Psychiatry; 1986 Jun; 47(6):305-9. PubMed ID: 2872206
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The relationship between negative symptoms of schizophrenia and extrapyramidal side effects with haloperidol and olanzapine.
    Allan ER, Sison CE, Alpert M, Connolly B, Crichton J.
    Psychopharmacol Bull; 1998 Jun; 34(1):71-4. PubMed ID: 9564201
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M, Shirakawa K, Matsuoka N, Mutoh S.
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA, Brecher M, Paulsson B.
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [Abstract] [Full Text] [Related]

  • 16. The continuing problem of extrapyramidal symptoms: strategies for avoidance and effective treatment.
    Gerlach J.
    J Clin Psychiatry; 1999 Oct; 60 Suppl 23():20-4. PubMed ID: 10625196
    [Abstract] [Full Text] [Related]

  • 17. Extrapyramidal side effects are unacceptable.
    Kane JM.
    Eur Neuropsychopharmacol; 2001 Oct; 11 Suppl 4():S397-403. PubMed ID: 11587887
    [Abstract] [Full Text] [Related]

  • 18. National prescribing patterns in the management of extrapyramidal symptoms among patients with schizophrenia.
    Luo RD, Belleti DA, Tran D, Arcona S, Salen PN.
    Int J Psychiatry Med; 2002 Oct; 32(3):261-9. PubMed ID: 12489701
    [Abstract] [Full Text] [Related]

  • 19. Antipsychotic treatment in older schizophrenia patients with extrapyramidal side effects in Asia (2001 - 2009).
    Xiang YT, Kreyenbuhl J, Dickerson FB, Ungvari GS, Wang CY, Si TM, Lee EH, Chiu HF, Lai KY, He YL, Yang SY, Chong MY, Tan CH, Kua EH, Fujii S, Sim K, Yong MK, Trivedi JK, Chung EK, Udomratn P, Chee KY, Sartorius N, Shinfuku N.
    Int J Clin Pharmacol Ther; 2012 Jul; 50(7):500-4. PubMed ID: 22541750
    [Abstract] [Full Text] [Related]

  • 20. [Extrapyramidal effects of antipsychotic drugs].
    Kulisevsky J, Otermin P.
    Neurologia; 2003 Jun; 18(5):262-8. PubMed ID: 12768512
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.